A female patient with obesity will soon begin treatment with ...

[mcmcdaniel]

A female patient with obesity will soon begin treatment with orlistat. The nurse should teach the patient that
 
  A) there will be fat present in her stools.
  B) her appetite will decline over the next 48 hours.
  C) she will have to increase her fiber intake.
  D) she will need to temporarily eliminate fats from her diet.

Question 2

A patient is diagnosed with infertility. What medication may the nurse administer for the treatment of infertility?
 
  A) Thyrotropin alfa (Thyrogen)
  B) Pegvisomant (Somavert)
  C) Menotropins (Pergonal)
  D) Somatotropin (Humatrope)

[essyface1]

Answer to Question 1

A
Feedback:
Fatty stools are a notable adverse effect of orlistat. This drug does not reduce appetite. A reduced-fat diet may be of benefit, but it is not necessary to wholly eliminate fats from the diet.

Answer to Question 2

C
Feedback:
Menotropins (Pergonal) is administered in combination with HCG to induce ovulation. Thyrotropin alfa (Thyrogen) is a synthetic formulation of TSH used as a diagnostic adjunct for serum thyroglobulin. Pegvisomant (Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly in adults. Somatotropin (Humatrope) is administered to children for impaired growth.

[mcmcdaniel]

Thanks

[essyface1]

Welcome